HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study.

AbstractBACKGROUND AIMS:
Mesenchymal stem cells/marrow stromal cells (MSC) represent a promising tool for stem cell-based clinical trials in amyotrophic lateral sclerosis (ALS). We present the results of long-term monitoring of 19 ALS patients enrolled in two phase I clinical trials of autologous MSC transplantation.
METHODS:
Nineteen patients (11 male and eightfemale) with ALS were enrolled in two consecutive phase I clinical trials. The patients were followed-up for 6-9 months and then treated with autologous MSC isolated from bone marrow and implanted into the dorsal spinal cord with a surgical procedure. The patients were monitored regularly before and after transplantation with clinical, psychological and neuroradiologic assessments every 3 months, at the tertiary referral ALS center in Novara (Italy), until death.
RESULTS:
Follow-up brain magnetic resonance imaging (MRI) revealed no structural changes (including tumor formation) relative to the baseline throughout the follow-up. There was no deterioration in the psychosocial status and all patients coped well. No clear clinical benefits were detected in these patients but the recruitment and selection of appropriate patients into larger trials will be needed to test the efficacy of the treatment.
CONCLUSIONS:
This study is the first to show the safety of MSC transplantation in the central nervous system during a follow-up of nearly 9 years, and is in support of applying MSC-based cellular clinical trials to neurodegenerative disorders.
AuthorsLetizia Mazzini, Katia Mareschi, Ivana Ferrero, Massimo Miglioretti, Alessandro Stecco, Serena Servo, Alessandro Carriero, Francesco Monaco, Franca Fagioli
JournalCytotherapy (Cytotherapy) Vol. 14 Issue 1 Pg. 56-60 (Jan 2012) ISSN: 1477-2566 [Electronic] England
PMID21954839 (Publication Type: Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Aged
  • Amyotrophic Lateral Sclerosis (pathology, psychology, surgery)
  • Bone Marrow (pathology)
  • Brain (diagnostic imaging, pathology)
  • Female
  • Follow-Up Studies
  • Humans
  • Italy
  • Magnetic Resonance Imaging
  • Male
  • Mesenchymal Stem Cell Transplantation
  • Middle Aged
  • Radiography
  • Spinal Cord (diagnostic imaging, pathology, surgery)
  • Transplantation, Autologous
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: